JPRN-UMIN000013356已完成未知
Effects of DPP4 inhibitor, sitagliptin or Sulfonylurea on intrahepatic adipose mass and lipid metabolism in patients with type 2 diabetes accompanied by fatty liver : a prospective randomized, open-label trial - Sitagliptin Effect on fatty liver and Lipid Metabolism study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who had diabetic ketosis, or diabetic pre-coma and coma within 6 months of the study entry. 2)Patients with severe infections, before or after operation, or with serious trauma. 3)Patients with pregnancy, possibility of pregnancy or having a breast feeding. 4)Patients with renal insufficiency (serum creatinine = and > 1.5 mg/dl) 5)Patients who received insulin therapy. 6)Patients who administered antihyperlipidemic agent other than Metformin for observation period. 7)Patients who had a history of hypersensitive reaction to DPP-4 inhibitor. 8)Patients whom the attending doctor estimated to be ineligible according to the medical rationale.
研究者
相似试验
已完成
不适用
Comparison of DPP-4 inhibitor, sitagliptin and nateglinide, and liraglutide and exenatide in type 2 diabetes: a CGM based-studyType 2 diabetes mellitusJPRN-UMIN000006799Yokohama City University Medical Center80
已完成
不适用
Comparison of DPP-4 inhibitors, vildagliptin and linagliptin in type2 diabetesType 2 diabetes mellitusJPRN-UMIN000010445Yokohama City University Medical Center100
Unknown
4 期
Study on Exploring the Effect of DPP-4 Inhibitors on β-cell Function by Using the Two-step Hyperglycemic ClampType 2 DiabetesNCT02386943Shanghai Jiao Tong University School of Medicine12
已完成
4 期
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and SulfonylureasProteinuriaType 2 Diabetes MellitusNCT03983551Changhua Christian Hospital101
进行中（未招募）
1 期
DPP-4 inhibition with sitagliptin and the risk for hypoglycaemia in the fasting state in subjects with type 2 diabetesEUCTR2016-004480-39-DEProfil Institut für Stoffwechselforschung GmbH20